CONSOLIDATED STATEMENTS OF CASH FLOWS UNAUDITED (USD $) In Thousands, unless otherwise specified	6 Months Ended		9 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Sep. 30, 2012
Cash flows from operating activities:
Net income (loss)	$ 106,573	$ 74,431
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation expense	28,520	24,478
Amortization expense	40,528	42,826
Debt redemption loss and costs, net		35,092	0
Other operating activities	0	4,196
Gain (Loss) on Sale of Business	28,786	5,903
Changes in assets and liabilities, net of effects from acquisition and divestiture of businesses:
Accounts receivable and unbilled receivables, net of provision for doubtful accounts	71,130	3,496
Inventories	(17,319)	68,535
Other current and noncurrent assets	(28,359)	6,821
Accounts payable	1,146	(66,829)
Accrued employee compensation	(8,873)	5,553
Current and noncurrent liabilities	40,537	16,113
Net cash flows from operating activities	262,669	220,615
Cash flows from investing activities:
Acquisition of businesses, net of cash received	(298)	(568)
Proceeds from Divestiture of Businesses, Net of Cash Divested	675	0
Capital expenditures	(46,837)	(46,435)
Other	625	(586)
Net cash flows used in investing activities	(45,835)	(47,589)
Cash flows from financing activities:
Payments on Term Loans	(10,626)	(11,250)
Payments on long-term borrowings and obligations	(3,434)	(26,046)
Option indexed to issuers equity cash paid	(38)	(48,126)
Increase (decrease) in cash overdraft balance	(10,233)	(7,318)
Payments for Omnicare common stock repurchases	100,302	80,307
Proceeds for stock awards and exercise of stock options, net of stock tendered in payment	16,532	4,159
Dividends paid	(28,766)	(15,521)
Other	1,180	(4,400)
Net Cash Provided by (Used in) Financing Activities	(135,687)	(188,809)
Net increase (decrease) in cash and cash equivalents	81,147	(15,783)
Cash and cash equivalents at beginning of period	454,213	580,262	580,262
Cash and cash equivalents at end of period	$ 535,360	$ 564,479